Nestlé Health Science partners with Enterome to treat food allergies and bowel inflammation
French Biotech firm Enterome, partly owned by the Lundbeck Foundation, has entered a strategic research and development partnership regarding food allergies and inflammatory bowel disease (IBD) with Nestlé Health Science, according to a company press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
ALK expects to have approved peanut allergy vaccine in 2030
For subscribers